Bio-identical hormones are biochemically modified hormones that closely mimic hormones formed naturally by the human body. Estrogen, progesterone, and testosterone are three of the most commonly synthesized hormones.
Levels of chemicals like testosterone, estrogen and progesterone in the body are brought down with movement in age, which prompts certain menopausal side effects in females like weight gain, night sweats, vaginal dryness, mood swings and vaginal pain due to sexual intercourse. In men, low testosterone level can cause reduced bone density and erectile dysfunction. Bio-identical hormones Market are utilized to treat people whose common chemicals levels are low or imbalanced. The bio-indistinguishable chemicals go about as a substitution for common chemicals and increment the hormonal levels in the body. This cycle is called bio-indistinguishable chemical substitution treatment (BHRT). Bio-identical hormones are accessible as creams, patches, pills, implants and injectables.
Get Your FREE Sample Copy of the Bio-identical Hormones Market Report 2021
Dynamics:
Factors, for example, expanding geriatric population and females in the menopausal age group are required to support the development of the bio- identical hormones market over the forecast period. For example, as per an article distributed in the National Center for Biotechnology Information (NCBI) in November 2019, almost 1.3 million ladies become menopausal consistently in the U.S and around 75% of the females experience vasomotor manifestations like night sweating, hot flashes and palpitations because of menopause.
Notwithstanding the previously mentioned factors, rising awareness about the bio- identical hormones replacement treatment (BHRT), combined with expanded screening of hormonal inadequacy is projected to fuel the market development over the forecast time frame. For example, as indicated by an investigation directed by analysts from the Obstetrics and Gynecology Department of Kafkas University in January 2019, in Turkey, almost 432 females out of 926 selected bio-indistinguishable chemical substitution treatment to treat their menopausal symptoms.
Got any Query? Feel free to ask us at: https://www.coherentmarketinsights.com/insight/talk-to-analyst/3293
An increased risk of breast cancer in females who use bio-identical hormone therapy is expected to inhibit the market over the forecast timeframe. According to a report published in The Lancet journal in September 2019, between 1992 and 2018, nearly 108,647 postmenopausal women developed breast cancer, with approximately 55,575 of these women using hormone therapy.
Regional Insights:
North America had the largest market share in 2018 owning to approvals and launches of bio- identical hormones around there. For example, in September 2018, TherapeuticsMD, Inc., a drug organization, dispatched Imvexxy, (estradiol vaginal additions) in the U.S. Imvexxy is utilized for getting moderate serious dyspareunia (vaginal agony related with sexual movement), because of menopause. Additionally, in June 2019, TherapeuticsMD, Inc. reported a permit and supply concurrence with Theramex, a drug organization committed to ladies’ wellbeing, to popularize IMVEXXY (estradiol vaginal supplements) and BIJUVA (estradiol and progesterone cases) outside of the U.S., besides in Canada and Israel.
Ask for PDF sample copy of the Bio-identical Hormones market report @ https://www.coherentmarketinsights.com/insight/request-pdf/3293
Table of Content
Global Bio-identical Hormones Market Research Report
Section 1: Global Bio-identical Hormones Industry Overview
Section 2: Global Economic Impact on Bio-identical Hormones Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Bio-identical Hormones Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Bio-identical Hormones Market Forecast
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837